Serotonin Release Assay Using LC-MS/MS for HIT Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing heparin-induced thrombocytopenia (HIT) face challenges in differentiating between pathogenic and clinically irrelevant antibodies, with existing serologic assays having low specificity and functional assays using radioactive materials being complex and less accessible.
Innovation Solution
A method using liquid chromatography and mass spectrometry to indirectly measure serotonin released from donor platelets challenged with a patient's specimen, eliminating the need for radiolabeled serotonin and providing a more sensitive and accurate test for HIT.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If serologic assays are used to detect HIT antibodies, then the assay sensitivity is high and negative results can exclude HIT, but the specificity is low and false positive results occur frequently
Solution Approach 1:
The patent introduces an intermediary substance (serotonin or stable labeled serotonin) that serves as a mediator between the HIT antibodies and the detection system. The antibodies bind to platelets and cause serotonin release, which is then detected by LC-MS/MS. This intermediary approach allows the assay to maintain high sensitivity while improving specificity by measuring the functional consequence of antibody binding rather than just antibody presence.
Solution Approach 2:
The patent replaces the traditional radioactive detection system with a mass spectrometry-based detection system. Instead of measuring radioactivity from radiolabeled serotonin, the system uses LC-MS/MS to detect and quantify serotonin or stable labeled serotonin based on their mass-to-charge ratio. This substitution eliminates the need for radioactive materials while maintaining detection sensitivity and improving assay safety and accessibility.
2Measurement precision
If functional assays using radiolabeled serotonin are used to measure platelet activation, then the diagnostic accuracy for true HIT is improved, but the complexity of performance increases and accessibility decreases
Solution Approach 1:
The patent replaces the complex radioactive detection system with a mass spectrometry-based system. The LC-MS/MS system detects serotonin based on its characteristic mass spectrum, eliminating the need for radioactive labeling, special safety protocols, and specialized training. This substitution maintains diagnostic accuracy while significantly reducing assay complexity and improving accessibility to routine clinical laboratories.
Solution Approach 2:
The patent changes the detection parameter from radioactivity measurement to mass-to-charge ratio measurement. By detecting serotonin based on its mass spectrum characteristics rather than radioactive emission, the assay maintains its ability to accurately measure platelet activation while eliminating the complexities associated with radioactive materials. This parameter change simplifies the assay procedure and improves safety without compromising diagnostic accuracy.
3Measurement precision
If radiolabeled serotonin is used in serotonin release assays, then platelet activation can be measured, but the use of radioactive materials introduces safety risks and regulatory complexities
Solution Approach 1:
The patent substitutes the radioactive detection mechanism with a mass spectrometry detection mechanism. Instead of using radiolabeled serotonin that emits radiation, the system uses stable labeled serotonin or endogenous serotonin detected by LC-MS/MS based on mass-to-charge ratio. This substitution completely eliminates radioactive material risks while maintaining the ability to accurately measure platelet activation through serotonin release.
Solution Approach 2:
The patent employs stable labeled serotonin as a non-radioactive alternative that can be used without the stringent safety and regulatory requirements associated with radioactive materials. Stable isotopes do not decay and do not pose radiation risks, making the assay safer and more accessible. The stable labeled serotonin serves as a disposable, safe alternative to radiolabeled compounds while providing the same analytical capability for measuring platelet activation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances diagnostic accuracy and sensitivity for HIT, allowing for the differentiation of pathogenic antibodies and reducing the complexity and risks associated with radioactive materials.
Implementation Method 1
chromatographically separating serotonin from other components in the incubated sample using liquid chromatography
Implementation Method 2
analyzing the chromatographically separated serotonin by mass spectrometry to determine the presence or amount of released serotonin
Data Source
AI summary
Disclosed are methods and systems for measuring serotonin in a sample using liquid chromatography and mass spectrometry.